News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
257 Results
Type
Article (11)
Press Release (246)
Section
Business (85)
Deals (16)
Drug Development (25)
FDA (4)
Job Trends (3)
News (127)
Policy (14)
Tag
Alliances (5)
Approvals (5)
Best Places to Work (3)
Biosimilars (3)
Clinical research (23)
Collaboration (1)
Compensation (12)
C-suite (2)
Data (4)
Earnings (67)
Events (42)
Executive appointments (1)
FDA (12)
Funding (2)
Government (2)
Guidances (2)
Healthcare (7)
IPO (14)
Legal (5)
Medical device (4)
Medtech (4)
Mergers & acquisitions (2)
NextGen: Class of 2026 (4)
People (26)
Phase 2 (17)
Phase 3 (8)
Pipeline (4)
Regulatory (15)
Series A (1)
Date
Last 30 days (1)
Last 365 days (41)
2026 (2)
2025 (45)
2024 (36)
2023 (38)
2022 (36)
2021 (30)
2020 (20)
2019 (13)
2018 (21)
2017 (8)
2016 (1)
2015 (3)
2014 (2)
2013 (1)
Location
Asia (6)
Australia (2)
California (52)
Europe (4)
Northern California (3)
Southern California (45)
United States (52)
257 Results for "evolus".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue
January 9, 2026
·
10 min read
Press Releases
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 14, 2025
November 17, 2025
·
1 min read
Press Releases
Evolus Announces the Appointment of Tatjana Mitchell as Chief Financial Officer
September 9, 2025
·
5 min read
Press Releases
Evolus to Report Second Quarter Financial Results on August 5, 2025
July 23, 2025
·
1 min read
Press Releases
Evolus Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 12, 2025
September 15, 2025
·
2 min read
Press Releases
Evolus Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 5, 2025
·
18 min read
Press Releases
Evolus Announces Commercial Launch of Evolysse™
April 16, 2025
·
4 min read
Press Releases
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 8, 2025
August 11, 2025
·
1 min read
Press Releases
Evolus Announces Publication of Independent Study in JAMA Dermatology Demonstrating Jeuveau® as a Top Performer Among Leading Neurotoxins
August 1, 2025
·
3 min read
Press Releases
Evolus Announces Positive Data From Pivotal Trial for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp
August 25, 2025
·
7 min read
1 of 26
Next
